Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 13, 2014, after the close
10-K filed Mar 13, 2014, 72 days after period end · 0000320017-14-000007
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures | Q4 2009dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $2.75M | — | — |
| Net Income | -$12.54K | -$15.51M | -$19.01M | — |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| EPS Diluted | -$0.47 | — | — | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
